#pgm3
yeah, although I think this is the only game specifically on PGM3.

the same chipset was used for a whole bunch of gambling / ticket type games though, but they weren't branded as PGM3
September 24, 2026 at 4:50 PM
OpenAI하고 Anthropic덕에 MAME가 엄청 활발해져서 좋네. 이젠 PGM3 보드 에뮬레이션 올라오네...
September 25, 2026 at 9:00 AM
I got a stack of #igs #pgm3 character #memorycards for shits n giggles. I don’t own a #knightsofvalour3hd or a PGM3 board yet, but figured it would be something cool to give away for home tournaments in the future. I needed a box to store these so I ended up getting this #sidewinder card box.
September 26, 2026 at 9:34 PM
Hoy el bueno de @blackonion.bsky.social me ha recordado este maravilloso sketch, hacía años que no lo veía :D

www.youtube.com/watch?v=o63j...
Oregón TV - T1 - PGM3 - Plaga notarios
YouTube video by Oregon TV
www.youtube.com
December 20, 2024 at 9:15 AM
Natural history of PGM3 deficiency in 10 patients:

Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiency url: rupress.org/jhi/article/...
Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiency | Journal of Human Immunity | Rockefeller University Press
PGM3 deficiency is a multisystem disorder characterized by recurrent infections, chronic severe neutropenia, and virus-associated malignancies, often leadi
rupress.org
December 13, 2025 at 12:04 PM
In new report, Wang, Freeman et al. summarize the clinical phenotypes, immunologic findings, treatment, and outcomes of 10 patients with Phosphoglucomutase-3 (PGM3) deficiency rupress.org/jhi/article/...

@clinimmsoc.bsky.social
December 12, 2025 at 5:15 PM
Very uncommon (at least in the USA) IGS PGM3 version of Knights of Valor 3 HD that I picked up last year and helped document the instructions and pcbs for igspgm.com
November 16, 2024 at 10:29 PM
PGM3 inhibition rewires RUVBL2-dependent DNA repair and induces a BRCAness-like state in pancreatic cancer cells https://www.biorxiv.org/content/10.64898/2026.08.31.746486v1
September 1, 2026 at 11:47 PM
Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiency. New research letter from Chen Wang, Alexandra Freeman and colleagues @niaidnews.bsky.social: rupress.org/jhi/article/...

#Autoimmunity #Atopy #ClinicalPhenotypes #InbornErrorsOfImmunity
@clinimmsoc.bsky.social
Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiency | Journal of Human Immunity | Rockefeller University Press
PGM3 deficiency is a multisystem disorder characterized by recurrent infections, chronic severe neutropenia, and virus-associated malignancies, often leadi
rupress.org
December 19, 2025 at 2:45 PM
@proteintech.bsky.social's resource, RRID:AB_2110243, was just reported to be used in the paper. Thanks for making your methods matter! #reproducibility #RRID #ReproducibleResearch
Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth
doi.org
May 7, 2025 at 11:00 PM
It would be extraordinary were we to find an enzyme to inhibit in the terrifying brain tumor GBM (killer of Ted Kennedy and McCain) to rival the kinase inhibitors of CML (leukemia).

Will we advance this quest with a crippled #NIH?

www.science.org/doi/10.1126/...
Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth
Hexosamine synthesis pathway and SCAP/SREBP-1 reciprocally enhance each other to drive malignant brain tumor growth.
www.science.org
April 19, 2025 at 5:00 PM
PGM3 inhibition rewires RUVBL2-dependent DNA repair and induces a BRCAness-like state in pancreatic cancer cells https://www.biorxiv.org/content/10.64898/2026.08.31.746486v1
September 1, 2026 at 11:47 PM
PGM3 (Barvix inc, 2014-05-31)

The final release of PGM3, game from is "as-is", however you may use the source to make your own engine or whatever, maybe release your own version of Pokemon Game Maker.
July 21, 2026 at 6:43 AM
Ohio State researchers identify PGM3 enzyme as potential breakthrough in glioblastoma treatment, offering new hope for combating aggressive brain cancers. Targeted therapies could revolutionize patient outcomes. #MedicalResearch #CancerTreatment
April 26, 2025 at 3:15 AM
Ohio State researchers identify PGM3 enzyme as potential breakthrough in glioblastoma treatment, offering new hope for combating aggressive brain cancers. Targeting molecular pathways could revolutionize cancer therapy. #MedicalResearch #CancerTreatment
April 25, 2025 at 11:52 PM
Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth
Science Advances
www.science.org/doi/10.1126/...
Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth
Hexosamine synthesis pathway and SCAP/SREBP-1 reciprocally enhance each other to drive malignant brain tumor growth.
www.science.org
April 23, 2025 at 6:31 AM
Research identifies key enzyme target to fight deadly brain cancers | #GBM #cancer
Research identifies key enzyme target to fight deadly brain cancers
Researchers have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the most dangerous type of brain tumor. Study findings are published online in the journal Science...
medicalxpress.com
April 20, 2025 at 2:47 PM
PGM3 version of Knights of Valour 3 HD “repaired” by actually plugging in a DVI cable. More photos and pcb/manual scans will be posted to <a href="http://igspgm.com" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">http://igspgm.com in the near future. #pgmref="/hashtag/pgm3" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#pgm3 #pgm #arcade #rtfm https://www.instagram.com/p/CoyLlL4rmyg/?igshid=YTgzYjQ4ZTY=
Tim's IGS POLYGAME MASTER (PGM) ARCADE SYSTEM
igspgm.com
November 16, 2024 at 9:17 AM
Feed: "Medical Xpress - latest medical and health news stories"
Published on Friday, April 18, 2025
Research identifies key enzyme target to fight deadly brain cancers
Researchers have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the most dangerous type of brain tumor. Study findings are published online in the journal Science Advances.
medicalxpress.com
April 21, 2025 at 2:49 PM
Feed: "Newswise: Latest News"
By: Ohio State University Wexner Medical Center on Friday, April 18, 2025
Research Identifies Key Enzyme Target to Fight Deadly Brain Cancers
Researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James and Richard J. Solove Research Institute (OSUCCC-James) have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the most dangerous type of brain tumor.
www.newswise.com
April 18, 2025 at 10:26 PM